Clinical Evaluation of the QuantiFERON CMV Assay

Stopped early

Conditions studied: CMV

In brief

Validate the use of the device in the clinical setting for assessing the risk of CMV Infection in SOT recipients after the completion of antiviral prophylaxis.

Key facts

Study ID

NCT03502161

Run by

QIAGEN Gaithersburg, Inc

People needed

8

Starts

2018-11-15

Expected to finish

2020-06-30

Last updated by the study team

2020-09-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult CMV D+/R- liver, kidney, heart, pancreas, lung, intestinal, or combined transplant recipients that are 18 years of age or older.
• Scheduled to receive between 3 to 6 months of antiviral prophylaxis
• Provide Informed Consent

You may not qualify if…

• Subjects less than 18 years old
• Scheduled to receive longer than 6 months or shorter than 3 months of prophylaxis
• Unable to provide Informed Consent

Where it is running

• University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.